Bulk Pharmaceutical API Sources for YUTOPAR

Bulk Pharmaceutical API Sources for YUTOPAR

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-003-959-434
BioChemPartner		BCP0726000243
TimTec		ST51015115
AbaChemScene		CS-2563
MedChemexpress MCE		HY-B0452
AKos Consulting & Solutions		AKOS024374986
BOC Sciences		23239-51-2

Bulk API Sources for YUTOPAR (Risperdal) (Risperidone)

Last updated: February 20, 2026

What Are the Main API Suppliers for Risperidone (YUTOPAR)?

YUTOPAR (risperidone) is an atypical antipsychotic medication with dual action on dopamine and serotonin receptors. The active pharmaceutical ingredient (API) risperidone is produced by multiple manufacturers globally, with a focus on quality, regulatory compliance, and supply consistency.

Primary API Manufacturing Regions

Region	Key Manufacturers	Market Share	Notable Certifications
China	Zhejiang Huahai Pharmaceutical, Jiangsu Hengrui Medicine, Zhejiang Topfond Pharmaceutical	Estimated 35-45%	GMP, ISO 9001, PIC/S
India	Strides Pharma, Sun Pharma, Aurobindo Pharma	Estimated 25-30%	US FDA, EMA, MHRA, GMP
Europe & US	Teva Pharmaceuticals, Mylan, Sandoz (Novartis), Dr. Reddy’s Labs (contract manufacturing)	Estimated 15-20%	US FDA, EMA
Other Regions	Fosun Pharmaceutical (China), Others	Remaining 10-15%	GMP, ISO

Leading API Manufacturers

China

• Zhejiang Huahai Pharmaceutical: Produces risperidone API conforming to GMP standards. Certified by CFDA, exports globally.
• Jiangsu Hengrui Medicine: Supplies risperidone API with ISO 9001 certification. Supplies primarily for domestic and Asian markets.
• Zhejiang Topfond Pharmaceutical: Holds multiple GMP certificates, supplies API to European and North American markets under CMOs.

India

• Strides Pharma: Manufactures risperidone API compliant with US and EU regulators. Multiple FDA-inspected plants.
• Sun Pharma: Produces risperidone API with international certifications, supplying global markets.
• Aurobindo Pharma: Has GMP-approved plants manufacturing risperidone API for global distribution.

Europe & US

• Teva Pharmaceuticals: Contract manufacturing, compliance with US FDA, European EMA standards.
• Mylan: Supplies risperidone API mainly through contract manufacturing, with regulatory approvals.
• Sandoz (Novartis): Offers risperidone API with extensive regulatory documentation.

Contract Manufacturing & Verifications

Many pharmaceutical companies purchase risperidone API from contract manufacturing organizations (CMOs), primarily in China and India, with API quality and certifications verifying compliance with international standards.

Regulatory and Quality Standards

• GMP Compliance: Essential for APIs intended for marketed drugs in the US, EU, Japan, and other markets.
• Certifications: Typically include ISO 9001, PIC/S, DMF filings, US FDA registration, EMA approval.
• Audit & Inspection Results: Leading suppliers maintain regular GMP inspections by authorities such as the US FDA and European EMA.

Key Considerations for API Selection

• Quality Certifications: Only manufacturers with recognized certifications should be considered.
• Regulatory Track Record: Manufacturers with a proven track record of successful filings in target markets.
• Supply Capacity & Lead Time: Evaluate manufacturer capacity to meet large-scale demand without supply disruptions.
• Pricing & Contract Terms: Competitive pricing often correlated with manufacturing region and volume.
• Traceability & Documentation: Suppliers should provide comprehensive batch and audit documentation.

Summary

The risperidone API landscape is concentrated in China and India, with the US and European manufacturers largely acting as intermediaries or contract manufacturers. Compliance with GMP and international certifications is mandatory; select suppliers with proven regulatory histories and sufficient capacity.

Key Takeaways

• China and India dominate risperidone API production, holding more than 60% of the supply market.
• Leading API producers in China include Zhejiang Huahai and Jiangsu Hengrui; India’s key players are Strides Pharma and Sun Pharma.
• Regulatory certification and consistent quality compliance are essential for supplier qualification.
• Contract manufacturing increases flexibility but requires rigorous supplier auditing.
• The global API supply chain for risperidone remains stable, with continuous capacity expansion in China and India.

FAQs

Q1: Which countries produce risperidone API at the highest regulatory standards?
A1: The US, European Union, and Japan require high GMP standards, with US FDA and EMA certifications predominant among manufacturers in China and India.

Q2: Are there risks associated with sourcing risperidone API from China or India?
A2: Yes, potential risks include regulatory compliance issues, supply chain disruptions, and quality variability. Ensuring supplier certifications and quality audits mitigate these risks.

Q3: How can I verify API supplier compliance?
A3: Verify through supplier certifications (GMP, ISO), review regulatory filings (DMF, ANDA), and conduct on-site audits when practical.

Q4: What is the typical lead time for risperidone API from major suppliers?
A4: Lead times range from 3 to 6 months, contingent on order volume and regulatory approval status.

Q5: What are the main quality concerns when sourcing risperidone API?
A5: Impurities, residual solvents, and potency deviations. Suppliers must provide detailed analytical data and stability profiles.

---

References

[1] World Health Organization. (2022). WHO Global Database on Raw Material & Active Pharmaceutical Ingredient Suppliers.
[2] U.S. Food and Drug Administration. (2023). Drug Master Files for API.
[3] European Medicines Agency. (2023). Guidelines on GMP for medicinal products.
[4] Pharmaceutical Technology. (2022). API manufacturing in China and India.
[5] IQVIA Institute. (2022). Global API Market Report.